Next Generation Sequencing (NGS) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Next-Generation Sequencing Market Growth & Analysis. The Industry is Segmented by Type of Sequencing (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, CHIP Sequencing, De Novo Sequencing, and Methyl Sequencing), Product Type (Instruments, Reagents, and Consumables, and Services), End User (Hospitals and Healthcare Institutions, Academics, and Pharmaceutical and Biotechnology Companies) Application (Drug Discovery and Personalized Medicine, Genetic Screening, Diagnostics, Agriculture and Animal Research, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecast are provided in terms of values in USD million for all the above-mentioned segments.

Next Generation Sequencing (NGS) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Next Generation Sequencing (NGS) Industry Overview

The next-generation sequencing (NGS) market is highly fragmented, with the presence of several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Illumina Inc., and PerkinElmer Inc., among others.

Next Generation Sequencing (NGS) Market Leaders

  1. Agilent Technologies

  2. F. Hoffmann-La Roche Ltd

  3. Illumina Inc.

  4. PerkinElmer Inc.

  5. Thermo Fisher Scientific Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Next-generation Sequencing (NGS) Market Concentration

Next Generation Sequencing (NGS) Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?